Dr. Mani Pharmaceutical Private Limited
About Dr. Mani Pharmaceutical Private Limited
Data last updated:
Dr. Mani Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 24 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33111UP2010PTC042969. Its GSTIN is 09AADCD9328G1ZH (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Abhay Mani Tripathi and Anita Mani Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at V – 85 Nehru Enclave, Lucknow, Uttar Pradesh, India – 226010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a growth of 34% compared to the previous year. For the same year it recorded a net profit of ₹1.04 Lakh (net margin 0.9%) and EBITDA of ₹3.65 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dr. Mani Pharmaceutical Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressV – 85 Nehru Enclave, Lucknow, Uttar Pradesh, India – 226010
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Dr. Mani Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr. Mani Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Dr. Mani Pharmaceutical Private Limited, buy the company report.
Financials of Dr. Mani Pharmaceutical Private Limited
FY 2024 filings availableDr. Mani Pharmaceutical Private Limited reported revenue of ₹1.21 Cr (up 34% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 34% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr. Mani Pharmaceutical Private Limited, buy the company report.
Board of directors of Dr. Mani Pharmaceutical Private Limited
Dr. Mani Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhay Mani Tripathi Also directs: Jagdish Memorial Foundation | Director | 24 Dec 2010 | 15 Years 10 Months | Current |
| Anita Mani Tripathi | Director | 24 Dec 2010 | 15 Years 10 Months | Current |
Peer comparison
Dr. Mani Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Na-Win Healthcare Private Limited | ₹1.22 Cr (FY 2025) | 78.0% | Bangalore, Karnataka, India | |||
| Hoap Health Intelligent Solutions Private Limited | ₹1.21 Cr (FY 2025) | -29.0% | Hyderabad, Telangana, India | |||
| Dr. Mani Pharmaceutical Private Limitedthis company | ₹1.21 Cr (FY 2025) | ₹1.04 Lakh | 0.9% | 34.0% | Lucknow, Uttar Pradesh, India | |
| RMM Healthcare India Private Limited | ₹1.21 Cr (FY 2022) | 29.0% | Bangalore, Karnataka, India | |||
| Healing Harmony Healthcare Solution Private Limited | ₹1.21 Cr (FY 2025) | 75.0% | Bengaluru, Karnataka, India |
To see the full peer comparison of Dr. Mani Pharmaceutical Private Limited, buy the company report.
Auditor
Dr. Mani Pharmaceutical Private Limited is audited by KUMAR DHINGRA & COMPANY for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR DHINGRA & COMPANY | FY 2018 | 023706N |
Shareholding
The shareholding of Dr. Mani Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Dr. Mani Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jan 2021 | 100436323 | Hdfc Bank Limited | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dr. Mani Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr. Mani Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dr. Mani Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCD9328G1ZH | Uttar Pradesh | Active | 04 Aug 2017 |
To see the full GST registrations and return filing status of Dr. Mani Pharmaceutical Private Limited, buy the company report.
Recent activity
Dr. Mani Pharmaceutical Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Abhay Mani Tripathi was appointed as Director on 24 Dec 2010.
Frequently asked questions
Dr. Mani Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 24 December 2010 (16+ years old) and is registered under CIN U33111UP2010PTC042969.
Dr. Mani Pharmaceutical has 2 current directors:
- Abhay Mani Tripathi - Director
- Anita Mani Tripathi - Director
The latest financial statements of Dr. Mani Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Dr. Mani Pharmaceutical is 09AADCD9328G1ZH, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Dr. Mani Pharmaceutical is U33111UP2010PTC042969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Mani Pharmaceutical was incorporated on 24 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Dr. Mani Pharmaceutical by revenue are Na-Win Healthcare Private Limited, Hoap Health Intelligent Solutions Private Limited, RMM Healthcare India Private Limited, Healing Harmony Healthcare Solution Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities).
Abhay Mani Tripathi was appointed as Director on 24 Dec 2010. Anita Mani Tripathi was appointed as Director on 24 Dec 2010.
The registered office of Dr. Mani Pharmaceutical is at V – 85 Nehru Enclave, Lucknow, Uttar Pradesh, India – 226010.
Dr. Mani Pharmaceutical operates in the healthcare industry, in the preventive health services segment.
Dr. Mani Pharmaceutical has open charges of ₹15 Lakh and no satisfied charges on record as per latest MCA filings.